VAERS Explorer
Back to explore

Report #2892524

Received Apr 13, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Mar 29, 2026
Onset
Mar 30, 2026
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1——

Symptoms (1)

Balance disorder

Symptom narrative

Dysequilibrium; This non-serious case was reported by a consumer and described the occurrence of dysequilibrium in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included hypothyroidism. Concomitant products included levothyroxine sodium (Levoxyl). On 29-MAR-2026, the patient received the 1st dose of Shingrix .5 ml. On 30-MAR-2026, 1 days after receiving Shingrix, the patient experienced dysequilibrium (Verbatim: Dysequilibrium). The outcome of the dysequilibrium was not resolved. It was unknown if the reporter considered the dysequilibrium to be related to Shingrix. It was unknown if the company considered the dysequilibrium to be related to Shingrix. Additional Information: GSK Receipt Date: 06-APR-2026 Patient have had multiple vaccines without any problems. This was the first time she have had ongoing difficulty with side effects. This disequilibrium was ongoing for over a week and she was seriously considering not getting her second shot. The batch number was not provided upon follow- up with the reporter.

Current illness

Hypothyroidism

Other medications

LEVOXYL